Covid-19: Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

Covid-19: Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

Ben Carson, the housing and urban development secretary, is the latest in a long line of Trump administration officials and associates to contract the virus. President-elect Joseph R. Biden Jr. announced his virus advisory board.

Here’s what you need to know:
The F.D.A. gave emergency approval to Eli Lilly’s antibody treatment.
At least three people at a White House election party last week have tested positive, including Ben Carson.
Biden adds vaccine official fired by Trump to his Covid-19 panel.
N.J. adds restrictions on restaurants and nightclubs, as N.Y.C.’s mayor calls the virus positivity rate spike ‘dangerous.’
Pfizer’s early data shows its vaccine is more than 90 percent effective.
Once again, Cuomo blasts Trump’s vaccine distribution plan, calling it ‘flawed.’
Ukraine’s president becomes the latest world leader to test positive for the virus.
Hungary and Portugal plan curfews and new restrictions as cases surge.
The F.D.A. gave emergency approval to Eli Lilly’s antibody treatment.

The Food and Drug Administration has granted emergency authorization of a Covid-19 treatment made by the American pharmaceutical company Eli Lilly that was given to Chris Christie, the former New Jersey governor, when he was infected with the coronavirus.

The authorization, announced on Monday, applies only to people newly infected with the virus, and the agency said it should not be used in hospitalized patients. The treatment is approved for people 12 and older who have tested positive and are at risk for developing a severe form of Covid-19 or being hospitalized for the condition. That includes people who are over 65 and obese, the agency said — a key group that early studies have shown can benefit the most from the treatment.